Chronic Liver Disease and the Risk of Osteoporotic Fractures: A Meta-Analysis
Open Access
- 16 September 2020
- journal article
- research article
- Published by Springer Nature in Cureus
- Vol. 12 (9)
Abstract
Chronic liver disease (CLD) causes more than 1 million deaths every year and remains a pandemic in the last decade affecting more than 600,000 patients in the United States. Previous studies found patients with CLD had increased risk of osteoporosis, so fractures were inferred to be complications of this condition. The aim of this meta-analysis is to summarize the best evidence that correlates CLD patients and the risk to develop osteoporotic fractures versus control patients without CLD. A review of the literature using MEDLINE and EMBASE database was performed during December 2017. We included cross-sectional and cohort studies that reported relative risks (RR), odds ratios (OR) and hazard ratios (HR) comparing the risk of developing osteoporotic fractures among patients with CLD versus patients without CLD. Pooled OR and 95% confidence interval (CI) were calculated using generic inverse- variance method. The Newcastle-Ottawa scale was used to determine the quality of the studies. Effect estimates from the individual study were extracted and combined using the random-effect, generic inverse variance method of DerSimonian and Laird. After the review of the literature, seven studies fulfilled the eligibility criteria established during the analysis. Significant association was found between CLD and osteoporotic fractures with a pooled OR of 2.13 (95% CI, 1.79 - 2.52). High heterogeneity among the studies was found (I2=88.5). No publication bias was found using Egger regression test (p=0.44). We found a significant association between CLD and the risk of developing osteoporotic fractures. The calculated risk was 2.13 times higher for patients with CLD when compared with controls. The results showed high heterogeneity but no publication bias. More prospective studies are needed to fully understand the mechanisms involved in loss of bone density and osteoporotic fractures in order to improve the morbidity associated with this disease.Keywords
This publication has 26 references indexed in Scilit:
- Patients with cirrhosis and ascites have false values of bone densityOsteoporosis International, 2011
- Management of osteoporosis in liver diseaseClinics and Research in Hepatology and Gastroenterology, 2011
- Hepatic osteodystrophy: An important matter for consideration in chronic liver diseaseWorld Journal of Hepatology, 2011
- Bone Disorders in Chronic Liver DiseasesCurrent Gastroenterology Reports, 2010
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesEuropean Journal of Epidemiology, 2010
- Hepatic osteodystrophy and liver cirrhosisWorld Journal of Gastroenterology, 2010
- Effect of Ascites on Bone Density Measurement in CirrhosisJournal of Clinical Densitometry, 2007
- Fracture Risk in People With Primary Biliary Cirrhosis: A Population-Based Cohort StudyGastroenterology, 2006
- Fracture risk of women with primary biliary cirrhosis: no increase compared with general population controlsAlimentary Pharmacology & Therapeutics, 2004
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986